سوق تطوير خطوط الخلايا العالمية - اتجاهات الصناعة والتوقعات حتى عام 2028

تحليل السوق ورؤى حول سوق تطوير خطوط الخلايا

تشير تحليلات Data Bridge Market Research إلى أن سوق تطوير خطوط الخلايا سيشهد معدل نمو سنوي مركب يبلغ حوالي 12.14% للفترة المتوقعة من 2021 إلى 2028. إن ارتفاع عدد المرضى في جميع أنحاء العالم، وارتفاع كفاءة البحث والتطوير، وزيادة الإنفاق العام والخاص على تطوير البنية التحتية للرعاية الصحية، وخاصة في الاقتصادات الناشئة، هي العوامل الرئيسية التي تعزى إلى نمو سوق تطوير خطوط الخلايا.

إن تطوير الخلايا الحية هو أحد منتجات علوم الحياة التي تُستخدم على نطاق واسع في مجموعة متنوعة من التطبيقات الضرورية. يساعد تطوير الخلايا الحية في عملية تطوير البروتين المعاد تركيبه. يساعد تطوير الخلايا الحية في توفير الوقت والجهد والتكلفة من خلال توفير الخلايا عالية الغلة.

إن الارتفاع المفاجئ في إنتاج اللقاحات على مستوى العالم، وخاصة بعد انتشار فيروس كورونا، يعد أحد العوامل الرئيسية التي تحفز نمو قيمة سوق تطوير سلالات الخلايا. كما أن زيادة اعتماد تقنيات الرعاية الصحية المتقدمة إلى جانب زيادة حالات الإصابة بالسرطان من شأنه أن يولد فرص نمو مربحة ومجزية لسوق تطوير سلالات الخلايا. كما أن نمو وتوسع قطاع التكنولوجيا الحيوية سيعمل أيضًا كعامل مهم في تحديد نمو سوق تطوير سلالات الخلايا.

ومع ذلك، فإن تكاليف رأس المال المرتفعة والنفقات المرتفعة المطلوبة لكفاءات البحث والتطوير من شأنها أن تخلق عوائق أمام سوق تطوير خطوط الخلايا. كما أن التعقيدات في تطوير خطوط الخلايا المستقرة من شأنها أن تزيد من تحدي معدل نمو السوق. كما أن الافتقار إلى سيناريو تعويض ملائم وغير كاف في الاقتصادات النامية والناشئة من شأنه أن يضعف معدل نمو السوق.

This cell line development market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on cell line development market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Cell Line Development Market Scope and Market Size

The cell line development market is segmented on the basis of product, source, cell line type and application. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• By product, the global cell line development market is segmented into reagents and media, equipment and accessories and consumables. Equipment segment is sub-segmented into incubators, centrifuges, bioreactors, storage equipment, microscopes, biosafety cabinets and cell counters and viability analysis systems.
• On the basis of source, the cell line development market is segmented into mammalian cell line and non-mammalian cell line. Non-mammalian cell line segment is sub-segmented into insects and amphibians.
• On the basis of cell line type, the cell line development market is segmented into recombinant cell lines, hybridomas, continuous cell lines and primary cell lines.
• On the basis of application, the cell line development market is segmented into bio production, drug discovery, toxicity testing, vaccines, tissue engineering, research and others.

Global Cell Line Development Market Country Level Analysis

Global cell line development market is analysed and market size insights and trends are provided by country, product, source, cell line type and application as referenced above.

The countries covered in the cell line development market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the cell line development market owing to the rising prevalence of presence of major research and academic institutes as well as biopharmaceutical companies and favourable reimbursement scenario in this region. Asia-Pacific on the other hand is projected to undergo the highest growth rate during the forecast period owing to the rapid healthcare infrastructure development.

The country section of the cell line development market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure growth Installed base and New Technology Penetration

The cell line development market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for cell line development market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the cell line development market. The data is available for historic period 2010 to 2019.

Competitive Landscape and Cell Line Development Market Share Analysis

The cell line development market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to cell line development market.

اللاعبون الرئيسيون الذين تم تغطيتهم في تقرير سوق تطوير خطوط الخلايا هم Eurofins Scientific و GENERAL ELECTRIC COMPANY و Lonza و F. Hoffmann-La Roche Ltd و Abbott و bioMérieux SA و Thermo Fischer Scientific, Inc. و Bio-Rad Laboratories. Inc و Danaher و Promega Corporation و Merck KGaA و Sartorius AG و Corning Incorporated و Cytovance Biologics و JSR Life Sciences, LLC و trenzyme GmbH و MabPlex International Ltd. و GenScript و Charles River Laboratories و Abzena Ltd من بين اللاعبين المحليين والعالميين الآخرين. تتوفر بيانات حصة السوق للعالم وأمريكا الشمالية وأوروبا وآسيا والمحيط الهادئ (APAC) والشرق الأوسط وأفريقيا (MEA) وأمريكا الجنوبية بشكل منفصل. يفهم محللو DBMR نقاط القوة التنافسية ويقدمون تحليلًا تنافسيًا لكل منافس على حدة.

SKU-45030